» Authors » G V Mazariegos

G V Mazariegos

Explore the profile of G V Mazariegos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 585
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shemesh E, Bucuvalas J, Anand R, Mazariegos G, Alonso E, Venick R, et al.
Am J Transplant . 2017 Mar; 17(10):2668-2678. PMID: 28321975
Nonadherence to immunosuppressant medications is a leading cause of poor long-term outcomes in transplant recipients. The Medication Level Variability Index (MLVI) provides a vehicle for transplant outcome risk-stratification through continuous...
2.
Shellmer D, DeVito Dabbs A, Dew M, Noll R, Feldman H, Strauss K, et al.
Pediatr Transplant . 2010 Oct; 15(1):58-64. PMID: 20946191
MSUD is a complex metabolic disorder that has been associated with central nervous system damage, developmental delays, and neurocognitive deficits. Although liver transplantation provides a metabolic cure for MSUD, changes...
3.
Mazariegos G, Steffick D, Horslen S, Farmer D, Fryer J, Grant D, et al.
Am J Transplant . 2010 Apr; 10(4 Pt 2):1020-34. PMID: 20420650
Improving short-term results with intestine transplantation have allowed more patients to benefit with nearly 700 patients alive in the United States with a functioning allograft at the end of 2007....
4.
McGuire B, Rosenthal P, Brown C, Busch A, Calcatera S, Claria R, et al.
Am J Transplant . 2009 Jul; 9(9):1988-2003. PMID: 19563332
No official document has been published for primary care physicians regarding the management of liver transplant patients. With no official source of reference, primary care physicians often question their care...
5.
Berg C, Steffick D, Edwards E, Heimbach J, Magee J, Washburn W, et al.
Am J Transplant . 2009 Apr; 9(4 Pt 2):907-31. PMID: 19341415
Liver transplantation numbers in the United States remained constant from 2004 to 2007, while the number of waiting list candidates has trended down. In 2007, the waiting list was at...
6.
Mazariegos G, Salzedas A, Zavatsky J, Sindhi R, Parizhskaya M, McGhee W, et al.
BioDrugs . 2007 Nov; 14(1):31-48. PMID: 18034554
The current management of hepatic allograft rejection after liver transplantation in children requires effective baseline immunosuppression to prevent rejection and rapid diagnosis and treatment to manage acute rejection episodes. The...
7.
Soltys K, Mazariegos G, Squires R, Sindhi R, Anand R
Am J Transplant . 2007 Jul; 7(9):2165-71. PMID: 17608834
Late graft loss (LGL) and late mortality (LM) following liver transplantation (LT) in children were analyzed from the studies of pediatric liver transplantation (SPLIT) database. Univariate and multivariate associations between...
8.
Strauss K, Mazariegos G, Sindhi R, Squires R, Finegold D, Vockley G, et al.
Am J Transplant . 2006 Feb; 6(3):557-64. PMID: 16468966
An 8.5-year-old girl with classical maple syrup urine disease (MSUD) required liver transplantation for hypervitaminosis A and was effectively cured of MSUD over an 8-year clinical follow-up period. We developed...
9.
McGhee W, Mazariegos G, Sindhi R, Abu-Elmagd K, Reyes J
Transplant Proc . 2002 May; 34(3):955-6. PMID: 12034258
No abstract available.
10.
Thomson A, Mazariegos G, Reyes J, Donnenberg V, Donnenberg A, Bentlejewski C, et al.
Transplantation . 2002 Mar; 72(8 Suppl):S13-22. PMID: 11888150
The mission of the recently established Immune Tolerance Network includes the development of protocols for the induction of transplant tolerance in organ allograft recipients and the development of assays that...